A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 2, 2002, Pages 105-113

  Halper, Lee K ^a   Johnson Pratt, Lisa ^a   Dobbins, Thomas ^a   Hartenbaum, David ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOBUNOLOL; TIMOLOL MALEATE;

ADULT; ARTICLE; BLEPHARITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; GEL; HEADACHE; HEART RATE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

EID: 0036217540     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076802317373860     Document Type: Article

References (7)

1. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension
2. Ocular beta-blockers in glaucoma management
3. Evaluation of timolol in gellan gum: A new vehicle to extend its duration of action
4. Timolol maleate in gel-forming solution: A novel formulation of timolol maleate
5. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure
6. A comparison of ocular hypotensive efficacy of twice-daily 0.25% levobunolol to 0.5% timolol in patients previously treated with 0.5% timolol
7. Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension